7月2日，微创机器人-B盘中上涨5.32%，报23.52港元，成交额2484.52万港元。
消息面上，公司近期公告核心产品图迈腔镜手术机器人全球商业化装机突破200台，第200台落地西班牙顶级医疗机构HM Hospitales，所有装机均已取得终端客户验收报告。此外，图迈全球商业化订单已突破300台，整体订单量接近400台，上半年新获订单已超去年全年总数。6月，图迈远程手术全科室应用获得欧盟CE认证，成为全球首个获该认证的远程手术机器人。目前图迈已在超60个国家和地区实现商业化装机，全球新增装机量位居国产第一、全球前二。瑞银、中信建投等机构均给予正面评级，看好公司海外销售潜力及收支平衡前景。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.